US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2328 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
FDA901, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
LY6161, High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores
ME1003, Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004
BRC961, Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR/ER/PR/Her-2(neu) IHC results, 48 cases/96 cores

Newly added tissue microarrays in recent month:

2015-08-26 NH1001a, Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing NH1001
2015-08-26 NH1001b, Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing NH1001
2015-08-24 BC08013b, Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC08013a
2015-08-24 HN601, Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases/60 cores
2015-08-24 LC819, Lung cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores
2015-08-24 NHL801a, Non-Hodgkin's lymphoma tissue array, 42 cases/80 cores, replacing NHL801
2015-08-24 OV2001a, Ovary cancer with adjacent normal ovary tissue array, including TNM, clinical stage and pathology grade, 200 cases/200 cores, replacing OV2001
2015-08-17 BR10010d, Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade and IHC markers (ER, PR, Her-2) results, 50 cases/100 cores, replacing BR10010c
2015-08-17 BR10011, Triple negative breast cancer tissue array, including TNM, clinical stage and pathology grade, IHC markers (ER, PR, Her-2) results, 100 cases/100 cores
2015-08-17 ES601, Esophagus squamous cell carcinoma tissue array with matched cancer adjacent esophagus tissue, including TNM, clinical stage and pathology grade, 30 cases/60 cores
2015-08-17 PR482a, Prostate cancer with normal prostate tissue array, including TNM, pathology grade, Gleason grade and gleason score, 24cases/48 cores, replacing PR482
2015-08-10 MS481b, Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases/48 cores, replacing MS481a
2015-08-10 FDA999h, Multiple organ normal tissue array, 97 cases/99 cores, replacing FDA999g
2015-07-29 BR487b, Triple negative breast cancer tissue array, including TNM, clinical stage and pathology grade, majority cases with negative of ER, PR, Her-2 in IHC, 48 cases/ 48 cores, replacing BR487a
2015-07-27 HBre-Duc140Sur-01, Breast carcinoma, 140 cases. 1 core/case.
2015-07-27 CO2601, Colon cancer tissue array with matched cancer adjacent colon tissue, including TNM, clinical stage and pathology grade, 65 cases/260 cores
2015-07-20 ES701, Esophagus cancer tissue array with matched adjacent normal esophagus tissue, including TNM, clinical stage and pathology grade, 35 cases/70 cores
2015-07-20 CO703, Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 35 cases/70 cores
2015-07-13 Top4-240a, High density tissue array of top 4 types of cancers with normal tissue control, including TNM, clinical stage, pathology grade and gleason score, 220 cases/240 cores, replacing Top4-240
2015-07-13 CO353, Colon adenocarcinoma (grade III) tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores